Factors associated with medicaid providers' recommendation of the HPV vaccine to low-income adolescent girls

Journal of Adolescent Health

Volumn 54, Issue 2, 2014, Pages 190-196

  Bynum, Shalanda A ^a   Staras, Stephanie A S ^b   Malo, Teri L ^c   Giuliano, Anna R ^c,d   Shenkman, Elizabeth ^b   Vadaparampil, Susan T ^c,d  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Adolescent; Barriers; Human papillomavirus vaccines; Low income population; Physicians

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; CHILD PARENT RELATION; DOCTOR PATIENT RELATION; FEMALE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICAID; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VACCINATION;

ADOLESCENT; BARRIERS; HUMAN PAPILLOMAVIRUS VACCINES; LOW-INCOME POPULATION; PHYSICIANS;

ADOLESCENT; ADOLESCENT PSYCHOLOGY; ATTITUDE OF HEALTH PERSONNEL; CHILD; FEMALE; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HUMANS; LOGISTIC MODELS; MEDICAID; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POVERTY; PROFESSIONAL-PATIENT RELATIONS; UNITED STATES; VACCINATION;

EID: 84892787304     PISSN: 1054139X     EISSN: 18791972     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2013.08.006     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention Vaccination coverage among adolescents aged 13-17 years - United States, 2007 MMWR Morb Mortal Wkly Rep 57 2008 1100 1103
2. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011 MMWR Morb Mortal Wkly Rep 61 2012 671 677
3. US Department of Health and Human Services Healthy People 2020 Washington, DC 2012
4. K.R. Ylitalo, H. Lee, and N.K. Mehta Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey Am J Public Health 103 2013 164 169
5. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010 MMWR Morb Mortal Wkly Rep 60 2011 1117 1123
6. Centers for Disease Control and Prevention Human papillomavirus- associated cancers - United States, 2004-2008 MMWR Morb Mortal Wkly Rep 61 2012 258 261
7. E.R. Myers, D.C. McCrory, and K. Nanda et al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis Am J Epidemiol 151 2000 1158 1171
8. L.E. Markowitz, E.F. Dunne, and M. Saraiya et al. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep Recomm Rep 56 2007 1 24
9. Centers for Disease Control and Prevention Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011 MMWR Morb Mortal Wkly Rep 60 2011 1705 1708
10. S.M. Garland, and J.S. Smith Human papillomavirus vaccines: Current status and future prospects Drugs 70 2010 1079 1098
11. D.M. Harper, and S.L. Vierthaler Next generation cancer protection: The bivalent HPV vaccine for females ISRN Obstet Gynecol 2011 2011 457204
12. L.M. Kester, G.D. Zimet, and J.D. Fortenberry et al. A national study of HPV Vaccination of adolescent girls: Rates, predictors, and reasons for non-vaccination Matern Child Health J 17 2013 879 885
13. M. Lau, H. Lin, and G. Flores Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health Vaccine 30 2012 3112 3118
14. A.G. Litton, R.A. Desmond, and J. Gilliland et al. Factors associated with intention to vaccinate a daughter against HPV: A statewide survey in Alabama J Pediatr Adolesc Gynecol 24 2011 166 171
15. M.R. Kramer, and A.L. Dunlop Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007 Matern Child Health J 16 Suppl 1 2012 S102 S110
16. M.F. Daley, L.A. Crane, and L.E. Markowitz et al. Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensure Pediatrics 126 2010 425 433
17. J.L. Young, R.G. Bernheim, and J.E. Korte et al. Human papillomavirus vaccination recommendation may be linked to reimbursement: A survey of Virginia family practitioners and gynecologists J Pediatr Adolesc Gynecol 24 2011 380 385
18. M. Javanbakht, S. Stahlman, and S. Walker et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community Vaccine 30 2012 4511 4516
19. K.M. Keating, N.T. Brewer, and S.L. Gottlieb et al. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer J Adolesc Health 43 4 Suppl 2008 S61 S67
20. E.L. McCave Influential factors in HPV vaccination uptake among providers in four states J J Community Health 35 2010 645 652
21. S.T. Vadaparampil, S.A. Staras, and T.L. Malo et al. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls Cancer 119 2013 621 628
22. D. Dillman Mail and internet surveys: The tailored design method 2000 Wiley New York, NY
23. S.T. Vadaparampil, J.A. Kahn, and D. Salmon et al. Missed clinical opportunities: Provider recommendations for HPV vaccination for 11-12 year old girls are limited Vaccine 29 2011 8634 8641
24. J.M. Riedesel, S.L. Rosenthal, and G.D. Zimet et al. Attitudes about human papillomavirus vaccine among family physicians J Pediatr Adolesc Gynecol 18 2005 391 398
25. J.A. Kahn, G.D. Zimet, and D.I. Bernstein et al. Pediatricians' intention to administer human papillomavirus vaccine: The role of practice characteristics, knowledge, and attitudes J Adolesc Health 37 2005 502 510
26. S.A. Staras, S.T. Vadaparampil, and L.T. Haderxhanaj et al. Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008 J Adolesc Health 47 2010 381 388
27. J.A. Bartlett, and J.A. Peterson The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: A review of the literature J School Nurs 27 2011 434 446
28. S.J. Hanley, E. Yoshioka, and Y. Ito et al. Acceptance of and attitudes towards human papillomavirus vaccination in Japanese mothers of adolescent girls Vaccine 30 2012 5740 5747
29. L.M. Niccolai, N.R. Mehta, and J.L. Hadler Racial/ethnic and poverty disparities in human papillomavirus vaccination completion Am J Prevent Med 41 2011 428 433
30. E.P. Simard, S. Fedewa, and J. Ma et al. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007 Cancer 118 2012 5110 5116
31. C.G. Dorell, D. Yankey, and T.A. Santibanez et al. Human papillomavirus vaccination series initiation and completion, 2008-2009 Pediatrics 128 2011 830 839
32. R.B. Perkins, S.B. Brogly, and W.G. Adams et al. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: A multicenter study J Women's Health 21 2012 813 820
33. GlaxoSmithKline Vaccine HPV Study Group, B. Romanowski, and P.C. de Borba et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomised placebo-controlled trial up to 6.4 years Lancet 374 2009 1975 1985
34. A. Hildesheim, R. Herrero, and S. Wacholder et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: A randomized trial JAMA 298 2007 743 753
35. B. Lu, A. Kumar, and X. Castellsague et al. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: A systematic review & meta-analysis BMC Infect Dis 11 2011 13
36. J. Paavonen, P. Naud, and J. Salmeron et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women Lancet 374 2009 301 314
37. A. Rowhani-Rahbar, C. Mao, and J.P. Hughes et al. Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine Vaccine 27 2009 5612 5619
38. N.T. Brewer, S.L. Gottlieb, and P.L. Reiter et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area Sex Transmit Dis 38 2011 197 204
39. J.A. Kahn, J. Xu, and G.D. Zimet et al. Risk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women J Adolesc Health 50 2012 464 470
40. T.L. Mullins, G.D. Zimet, and S.L. Rosenthal et al. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination Arch Pediatr Adolesc Med 166 2012 82 88